The Lancet Diabetes & Endocrinology, dedicated to covering the disciplines of diabetes, endocrinology, and metabolism, is the latest title in The Lancet family of specialty journals. Continuing in The Lancet's tradition of publishing high-impact content that influences medical practice, each monthly issue of The Lancet Diabetes & Endocrinology will contain Original Research, Reviews, Comments, and News. The Lancet Diabetes & Endocrinology is stringently edited and peer-reviewed to ensure the scientific merit and clinical relevance of its diverse content. Original Research is fast-tracked to publication within 8 weeks on average of submission and published Online First on TheLancet.com before the print issue.
In 2007, the teams of Massimo Terzolo and Martin Fassnacht published a study in the New England Journal of Medicine that provided evidence for the efficacy of mitotane in the prevention of recurrence in adrenocortical carcinoma. ...
Aug 24, 2023
0
2
Diabetes is a condition in which the body produces too little or no insulin. Diabetics thus depend on an external supply of this hormone via injection or pump.
Aug 23, 2023
0
97
Structural racism and geographic inequity are advancing the global crisis of diabetes, leaving people with diabetes 50% more likely to develop cardiovascular disease and twice as likely to die compared to those without diabetes, ...
Jun 27, 2023
0
16
The hormone oxytocin is important for social interaction and to control emotions. A deficiency of this hormone has previously been assumed in various diseases such as autism, but has never been proven. Now, for the first ...
May 15, 2023
0
31
Lean, metabolically unhealthy, people have a risk of cardiovascular disease (CVD) that is higher than the risk observed in obese, metabolically healthy people. Recently, novel cluster analyses (computer-based grouping of ...
May 8, 2023
0
12
An international study shows that it is likely that insulin can be stored at room temperature, and for considerably longer than drug companies have counted on to date. Access to this vital medicine can thereby be significantly ...
Apr 11, 2023
0
28
The incidence of type 1 and type 2 diabetes is increasing among children and young people aged 0 to 19 years, according to a study published in the April issue of The Lancet Diabetes & Endocrinology.
Mar 31, 2023
0
3
More children and adolescents than usual developed type 1 diabetes in Finland in the first 18 months of the coronavirus pandemic. According to a recently completed study, the cause was not the novel coronavirus, but altered ...
Mar 23, 2023
0
60
For young people, empagliflozin is associated with improvement in glycated hemoglobin (HbA1c), according to a study published in the March issue of The Lancet Diabetes & Endocrinology.
Mar 21, 2023
0
0
New findings from researchers at Wake Forest University School of Medicine confirm that the rates of Type 1 and Type 2 diabetes continue to increase in children and young adults. Non-Hispanic Black and Hispanic children and ...
Mar 6, 2023
0
15
